Natick

Natick pharmaceutical company Karyopharm Therapeutics said its leading drug candidate has received federal designation as an “orphan drug” to help treat acute myeloid leukemia (AML).

A two-story office building on the westbound side of Route 9 in Natick has been sold for $2.7 million and will house the new headquarters of a staffing firm currently based in Framingham, according to a brokerage firm involved in the deal.

Dr. Michael Kauffman, CEO of Natick pharmaceutical startup Karyopharm Therapeutics Inc., entered the medical field because he...

On the heels of its recently announced acquisition of IoGyn Inc., Natick-based pharmaceutical company Boston Scientific Corp. (BSX) announced it will acquire the Interventional Division of Bayer AG for $415 million in cash.

Boston Scientific said it received a subpoena last week from federal regulators, seeking documents about some of its heart devices.

International clothing store chain Uniqlo will open its first permanent Massachusetts store in Natick later this year, the company announced last week.

Natick-based pharmaceutical company Boston Scientific Corp. (BSX) announced it will acquire IoGyn Inc, a clinical-stage company that has received FDA approval on a system designed to treat uterine fibroids and polyps.

Cognex Corp. of Natick said a federal jury has ruled in the company's favor in a patent infringement lawsuit it brought against a Washington state firm last year.

In a move it believes will improve its position in the Japanese drug-eluting stent market, Natick-based Boston Scientific Corp. (BSX) announced Thursday the launch of Promus Premier Stent System in the Asian country.

Machine-sensor manufacturer Cognex Corp. of Natick will buy back another $50 million of its stock, following its launch of an existing $80-million repurchase program, the company announced.